Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

Apremilast shows promise for several skin conditions but needs more research.

HIV can cause skin disorders, which are often the first sign of infection, especially in people with darker skin.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Acupuncture and moxibustion may help treat hair loss, but more research is needed.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Higher doses of isotretinoin may lead to more hair loss.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Laser hair removal is popular for long-term hair reduction but carries risks, requiring well-trained operators and better regulations, especially in South Africa.

Topical tofacitinib is effective and safe for treating alopecia areata.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

Regenerative medicine is effective and safe for treating vitiligo.

Vitamin A might be a safe extra treatment for dogs with sebaceous adenitis, but more research is needed to prove its effectiveness.

Curcuma aeruginosa extract combined with minoxidil effectively treats male-pattern baldness.